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Summary. The impact of birth before 27 completed weeks of gestation on infant pulmonary
function (PF) was explored in a multi-ethnic population in comparison to more mature preterm
controls (PTC) and healthy fullterm infants. Plethysmographic lung volume (FRCpleth) and forced
expiredvolume (FEV0.5) were obtained at12months post-termage in 52 extremely preterm (EP)
infants (median [range] gestational age [GA]: 26 [23–27] weeks; 40% White mothers; 79% with
BPD), 41 PTC (GA:35 [30–36] weeks; 37%Whitemothers) and 95 fullterm infants (GA:40 [37–42]
weeks; 86% White mothers). Using reference equations based on identical equipment and
techniques, results were expressed as z-scores to adjust for age, sex and body size. FEV0.5 was
significantly lower in EP infants when compared with PTC (mean difference [95% CI]: 1.02
[1.60; 0.44] z-scores, P<0.001), as was forced vital capacity (FVC) but there were no
significant differences in FRCpleth or FEV0.5/FVC ratio. FEV0.5, FVC, and FEV0.5/FVC were
significantly lower in both preterm groups when compared with fullterm controls. On multivariable
analyses of the combined preterm dataset: FEV0.5 at 1 year was 0.11 [0.05; 0.17] z-scores
higher/week GA, and 1.28 (0.49; 2.08) z-scores lower in EP infants with prior BPD. Among non-
white preterm infants, FEV0.5 was 0.70 (0.17; 1.24) z-scores lower, with similar reductions in FVC,
such that there were no ethnic differences in FEV0.5/FVC. Similar ethnic differences were
observed among fullterm infants. These results confirm the negative impact of preterm birth on
subsequent lung development, especially following a diagnosis of BPD, and emphasize the
importance of taking ethnic background into account when interpreting results during infancy as in
older subjects. Pediatr Pulmonol. 2014; 49:679–687.  2013 Wiley Periodicals, Inc.
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INTRODUCTION
Preterm birth is one of the most important factors
influencing an infant’s subsequent health and survival,
with long term adverse effects on pulmonary function
(PF) throughout childhood and into early adulthood.1–4
Advanced obstetric and neonatal care has resulted in
increased survival of extremely preterm (EP) infants but
the impact of extreme prematurity on lung development
during infancy has yet to be determined. While a
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significant improvement in survival was noted in the 2006
EPICure cohort of EP infants when compared to that
recruited in 1995, the pattern of major neonatal morbidity
and the proportion of survivors affected were unchanged,
indicating an important increase in the number of preterm
survivors at risk of later health problems.5
It is now recognized that much of the burden of adult
pulmonary disease has its origins in early life6 with
“tracking” of PF throughout the life-course, that is, those
with lower PF in the early years tending to retain this
position thereafter.7 However, the true impact of
prematurity on subsequent lung development can only
be determined if other important determinants, including
somatic growth and ethnic origin, are taken into
account.8,9 When compared with women of other ethnic
backgrounds, Black women are 3–4 times more likely to
have a very early preterm birth,10,11 and ethnic differences
in neonatal respiratory morbidity have been reported.12
The current observational study explored the impact of
extreme prematurity (EP) on PF in a multi-ethnic urban
UK population by comparing results from infants born EP
(EP: defined as birth up to and including 26 weeks and
6 days gestation, hereafter referred to as <27 weeks) at
1-year post-term age (where “term” is defined as
40 weeks post-menstrual age), with those from more
mature “healthy” preterm control (PTC) infants of similar
age and ethnic background, after adjustment for age, sex
and body size. Results were also compared with those
from healthy fullterm infants studied during a similar time
period using identical equipment and methods. We
hypothesized that, after adjusting for potential confound-
ers, PF at 1 year of age would be significantly associated
with gestational age.
MATERIALS AND METHODS
Subjects
Infants born <27 weeks gestation were recruited
between September 2006 and March 2008 from the
Neonatal Unit at the Homerton University or University
College Hospitals, London. A contemporaneous control
group (born 27 but <37 weeks gestation) comprising
preterm infants who required minimal ventilatory support
(no invasive ventilation, <6 hr nasal continuous positive
airway pressure (CPAP) and/or 48 hr supplemental
inspired oxygen (O2) following delivery) and without
any neonatal respiratory problems was also recruited.
Results from both groups were compared with those from
fullterm healthy infants whowere recruited as controls for
on-going clinical and epidemiological research studies
(2002–2011).13,14 Approval for this study was granted by
UCL Institute of Child Health/Great Ormond Street
Hospital Research Ethics Committee (REC#05/Q0508/
141) and written parental consent was obtained for all
infants.
Infant Pulmonary Function Tests
All pulmonary function assessments were measured
by the same investigators using identical protocols and
equipment at either the Homerton Hospital or UCL
Institute of Child Health. Measurements were undertaken
when infants were clinically well and free of symptoms,
with an interval of 2 weeks since any respiratory
symptoms. Infants were examined clinically and weighed
prior to sedation with oral chloral hydrate (60–100mg/
kg). Crown-heel length was measured using a calibrated
stadiometer. Weight and length at time of test were
expressed as z- (i.e., standard deviation) scores to adjust
for sex and post-term age.15 Pulmonary function tests
(PFTs) were undertaken between 7 and 15 months post-
term age during behaviourally determined “quiet” sleep.
The Jaeger Masterscreen BabyBody System (v.4.65;
CareFusion, Yorba Linda, CA) was used to measure
plethysmographic functional residual capacity (FRCpleth)
16,17
followed by forced expiratory maneuvers from an
inflation pressure of 30 cmH20 using the raised volume
technique.18 PFT results were expressed as z-scores to
adjust for post-term age, height and sex, using reference
equations derived from healthy fullterm infants, many of
whom were studied during the same time period, by the
same team, using identical methods and equipment.16,19
Data Management and Sample Size
Following quality control, PFT results were electroni-
cally exported to a research database (Re-Base software,
Re-Base Ltd., London, UK), which also contained all
relevant demographic and clinical details. Data analyses
were undertaken using IBM SPSS Statistics (v20,
Armonk, New York): comparisons between the two
preterm study groups were analyzed using independent
sample t-tests with 95% confidence intervals (CI) for
continuous data and chi-square or Fisher exact tests where
appropriate for categorical outcomes. Comparisons
between the two preterm groups and fullterm infants
were undertaken using ANOVA.Multivariable regression
analyses were performed to estimate the association of
prematurity, BPD and ethnicity with pulmonary function.
Taking into account two primary outcomes (FEV0.5 and
FRCpleth), a sample size of 43 infants per group would
allow detection of differences equivalent to 0.5 z-scores
with 90% power at the 5% significance level.20
RESULTS
In total, PFTs were attempted in 113 preterm infants
representing 77% of EP and 61% PTCs whose families
were approached (Fig. 1). Technically acceptable datasets
were available from 93 infants, with similar success rates
(80%) for both groups (Fig. 1).
Results were available from 52 EP infants (GA: range
23.4–26.9 weeks) and 41 PTC (GA: range 30.0–36.4
680 Hoo et al.
Pediatric Pulmonology
weeks; Table 1). There were no differences in sex
distribution, birth-weight z-score or exposure to pre- or
post-natal tobacco smoke between groups. Significantly
more (24% vs. 8%) PTC than EP infants were born small-
for-gestational age (SGA: birthweight <10th percentile
for gestation), with twice as many girls than boys being
born SGA in both these groups (data not shown). Cotinine
analysis of infant urine [median (range): 0.9 (0.1–
20.4) ng/ml] or maternal saliva [median (range): 0.2
(0.1–2.2) ng/ml] at time of test in reported non-smoking
mothers were compatible with no active smoking (i.e.,
<50 ng/ml in urine and <12 ng/ml in saliva).21 Ninety
percent (43/52) of those born EP received antenatal
steroids, with 94% receiving postnatal surfactant therapy.
Duration of supplemental oxygen for the EP group during
the neonatal period ranged from 1 to 96 (median: 28.6)
days, while that of intermittent positive pressure ventila-
tion, with and without nasal CPAP, ranged from 13 to 143
(median: 64.5) days and 1–116 (median: 25.5) days,
respectively. Seventy-nine percent (41/52) of EP subjects
were still receiving supplemental oxygen at 36 weeks
post-menstrual age and were thus classified as having had
bronchopulmonary dysplasia (BPD) (46% with moderate
BPD; 33% with severe BPD).22 Significantly more EP
infants had been prescribed bronchodilators and/or had
experienced lower respiratory tract illness (LRI) since
discharge from the neonatal unit when compared with
PTC infants (Table 1). Twelve percent EP infants required
hospital admission due to LRI prior to testing; none of the
PTCs had been hospitalized.
Table 2 compares demographics at time of test and
pulmonary function results between the two groups of
preterm infants, with results from healthy fullterm infants
included for comparison. A similar percentage of EP and
PTC infants were born to White European mothers
(40%), whereas twice as many fullterm infants were
White. At the time of test, the EP group was slightly older
Fig. 1. Flow diagram showing success rates in relation to
recruitment and achievement of technically acceptable infant
pulmonary function outcomes. Footnote: w, weeks; GA, gesta-
tional age; FEFV, forced expiratory flow-volume data from the
raised volume technique.
TABLE 1—Comparison of Background Characteristics in Preterm Infants
EP (n¼ 52) PTC (n¼ 41) D (95% CI), EP–PTC
Boys (%) 25 (48%) 26 (63%) 15% (34%; 5%)
Gestational age (weeks) 25.6 (1.0) 34.7 (1.3) 9.1 (9.6; 8.6)
Birth weight (kg) 0.80 (0.1) 2.21 (0.5) 1.4 (1.6; 1.2)
Birth weight z-score1 0.3 (0.7) 0.4 (1.1) 0.1 (0.3; 0.5)
Birthweight <10th percentile1 (%) 4/52 (8%) 10/41 (24%) 17% (32%; 2%)
Maternal smoking, antenatally 5 (10%) 3 (7%) 2% (11%; 14%)
Maternal smoking, postnatally 5 (10%) 10 (24%) 15% (31%; 0%)
Maternal antenatal steroids 43 (90%)2 20 (50%)3 40% (21%; 56%)
PROM >24 hr 20 (51%)4 12 (31%)4 21% (1%; 40%)
Prior respiratory morbidity
(a) Bronchodilator ever 19/42 (45%) 5/38 (13%) 32% (12%; 49%)
(b) LRI post discharge 12/42 (29%) 2/38 (5%) 23% (7%; 39%)
Data presented as n (%) or mean (SD).
EP, extremely preterm; PTC, preterm control; PROM, prolonged rupture of membranes; LRI, lower respiratory illness.
D mean difference between groups.
1Calculated using the UK-WHO algorithm.15
2n¼ 48.
3n¼ 40.
4n¼ 39.
P 0.05.
P 0.01.
P 0.001.
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than the PTCs. After correction for age and sex, weight,
length and body mass index were similar at time of test
between the two preterm groups but were lower than that
observed in fullterm infants (Table 2).
After adjusting for body size, age and sex,16 there was
no significant differences in FRCpleth between the preterm
groups, although values in PTC were 0.5 (0.2; 1.1)
z-scores lower than in EP infants. By contrast, forced
expiratory volumes (FEV0.5 and FVC) and flows (FEF25–75)
were significantly lower in EP children when compared to
PTCs (allP< 0.001; Table 2 and Fig. 2). The FEV0.5/FVC
z-score23 was somewhat, but not significantly, lower in
those born EP than in PTC (P¼ 0.15). Neither back-
ground demographics nor PFT results were influenced by
the center fromwhich infants had been recruited (data not
shown).When compared with results from the 95 fullterm
healthy infants of similar age, whose mean (SD) z-scores
for all pulmonary function outcomes were close to the
expected values of 0(1),24 FEV0.5, FEF25–75 and FEV0.5/
FVC were significantly lower in both groups of preterm
infants (Table 2).
Univariable analyses were undertaken within the EP
group to explore the associations between PFT outcomes
and potential explanatory variables. After adjustment for
body size, age and sex by expressing results as z-scores,
there were no additional significant determinants of
FRCpleth. By contrast, gestational age, administration of
surfactant, mechanical and/or CPAP ventilation, BPD,
birth-weight, male sex, having a White mother, and
maternal smoking postnatally were all independently
and significantly associated with FEV0.5, FEF and FVC at
1 year of age.
When these explanatory variables were included in
multivariable analyses of the entire preterm dataset, only
gestational age or BPD, having aWhite mother and being
male remained significantly associated with FEV0.5 and
FVC. On multivariable analyses, each additional week
of GAwas associated with increment of 0.10 (0.04; 0.16)
z-score for FEV0.5 and 0.08 (0.03; 0.13) z-score for FVC
at 1 year of age; similar results being observed for
FEF25–75 (data not shown). Prior diagnosis of BPD was
associated with a reduction in FEV0.5 and FVC z-scores
by 1.7 [2,4; 1.1], and 1.2 [1.7; 0.7],
respectively (Fig. 2), although GA was no longer
significant once BPD was included in this model. On
multivariable analysis, FEV0.5 was 0.70 (0.17; 1.24)
z-score lower among non-white preterm infants, with
similar reductions in FVC, such that there was no
difference in FEV0.5/FVC. These ethnic differences were
of similar magnitude when analysis was restricted to the
TABLE 2—Demographics at Time of Test and Pulmonary Function Results
Term controls (n¼ 95)
EP versus PTC
D (95% CI) EP–PTC(n¼ 52) (n¼ 41)
Age (weeks)þ 48.7 (14.2) 58.2 (11.8) 48.0 (6.8) 10.3 (6.4; 14.1)
Weight z-score 6¼ 0.5 (1.0) 0.20 (1.3) 0.003 (1.0) 0.2 (0.7; 0.3)
Length z-score 6¼ 0.8 (1.1) 0.11 (1.4) 0.59 (1.2) 0.5 (1.0; 0.1)
BMI z-score 0.03 (0.9) 0.35 (1.1) 0.45 (0.9) 0.1 (0.3; 0.5)
Ethnicity
White mothers 82 (86%) 21 (40%) 15 (37%) 4% (16%; 23%)
Black mothers1 10 (10%) 22 (42%) 14 (34%) 8% (12%; 27%)
Other2 3 (3%) 9 (17%) 12 (29%) 12% (29%; 5%)
Pulmonary function results
6FRCpleth, z-score
3 0.13 (1.1) 0.06 (1.8) 0.52 (1.0) 0.5 (0.2; 1.1)
7FEV0.5 z-score
4 0.17 (0.9) 1.62 (1.4) 0.61 (1.4) 1.0 (1.6;0.4)
7FVC z-score4 0.15 (1.0) 0.92 (1.1) 0.17 (1.1) 0.8 (1.2; 0.3)
7FEF25–75 z-score
4 0.06 (1.0) 1.8 (1.7) 0.74 (1.4) 1.1 (1.7; 0.5)
7FEV0.5/FVC z-score
5 0.12 (0.8) 0.89 (0.8) 0.62 (0.9) 0.3 (0.6; 0.1)
Data presented as mean (SD) or n (%).
D (95% CI) in bold font denotes significant differences in body size and pulmonary function results between the two preterm groups. Differences
with respect to the fullterm group were assessed using ANOVA and are summarized in text.
EP, extremely preterm; PTC, preterm controls; BMI, body mass index.
D, mean difference between groups; þ, age at time of test corrected for gestation; 6¼, calculated using the UK-WHO algorithm.15
P 0.001 for t-tests between EP and PTC groups.
1Including Afro-Caribbean and African mothers.
2Includes infants born to mothers of mixed ethnic origins, Asian or Chinese mothers.
3Calculated according to Nguyen et al.16
4Calculated according to Lum et al.19
5Calculated according to Jones et al.23
6n¼ 41 for EP, 35 for PTC and 74 for term controls for FRCpleth.
7n¼ 49 for EP, 41 for PTC and 89 for term controls for forced expiratory volumes and flows.
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36 “Black,” rather than all the “non-white” preterm
infants. Amongst preterm infants, boys had significantly
higher values of FEV0.5 and FVC than girls (0.98 [95%
CI: 0.40; 1.57] and 0.66 [0.18; 1.13] z-scores, respective-
ly). The FEV0.5/FVC ratio was not influenced by sex,
ethnicity or prior BPD, the only significant association
being with GA; increasing by 0.05 (0.03; 0.07) z-score for
each additional week of gestation (Fig. 3).
When expressing PF data from the fullterm healthy
infants as z-scores (Table 2), results were, as expected,
independent of sex, age and body size. Despite the
relatively low numbers, FEV0.5, FVC, and FRCpleth were
all significantly lower in “non-white” infants by 0.74
(95% CI: 0.20; 1.28, P¼ 0.008), 0.84 (0.24; 1.43,
P¼ 0.006) and 0.52 (0.06; 0.98, P¼ 0.029) z-scores,
respectively. As in the preterm groups, the FEV0.5/FVC
ratio was independent of ethnicity (Fig. 3).
DISCUSSION
This study demonstrates clear evidence of diminished
lung function at 1-year of age in infants born EP when
compared either with contemporaneous PTCs or with
healthy fullterm infants, after adjusting for important
determinants including age, sex, body size, and ethnicity.
Lung function was significantly associated with gesta-
tional age, and was significantly diminished even in PTCs
without neonatal lung disease when compared to healthy
fullterm infants. Among the EP children, this association
appeared to be largely mediated through the concomitant
diagnosis of BPD which remains so prevalent in such
immature infants.5,25 After adjustment for BPD or
gestational age, age, and body size, both FEV0.5 and
FVC (but not their ratio) were significantly lower among
non-white infants than in their white peers.
The strengths of this study include the fact that
although infants were tested on two sites, all were
assessed by the same team using identical methods and
equipment, with equipment-specific reference data being
used to adjust for age, sex and body size at time of test to
avoid any bias in interpretation.16,19 We have previously
demonstrated that use of appropriate reference equations
is essential for interpretation of infant forced expiratory
flow-volume (FEFV) and FRCpleth data,
16,19 collected
Fig. 2. The influence of bronchopulmonary dysplasia and gestational age on pulmonary function
at 1 year of age in infants born preterm. Footnote: EP, extremely preterm infants (n¼52), PTC,
preterm control infants (n¼41), BPD, bronchopulmonary dysplasia. Dashed lines indicate the
lower limit of normality (1.96 z-scores) in healthy fullterm infants.19,23 Symbols: Solid and open
triangles represent EP infants with and without BPD, respectively; open squares denote preterm
controls.
Fig. 3. The association between FEV0.5/FVC z-scores and
gestational age according to ethnicity. Footnote: Symbols:
triangles represent extremely preterm infants, squares: preterm
controls and circles: fullterm controls. Open and solid symbols
denote those born towhite and non-whitemothers, respectively.
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using the infant Jaeger Masterscreen system, in order to
avoid mis-diagnosis of lung disease.
Given that 77% of eligible families agreed to
participate, it is likely that the EP group was representa-
tive of the entire cohort surviving during the study period.
Furthermore, the incidence of BPD in our study was
similar to that recently reported for the entire 2006
EPICure2 cohort5 emphasizing the fact that “new” BPD is
very much a disease of immaturity. The ethnic mix of the
EP and PTC groups was similar and reflects the local
population of the multi-ethnic East London community.
By using multivariable regression analysis, we were able
to investigate the potential impact of ethnicity on infant
pulmonary function over and above that of prematurity.
There was only sufficient power to classify infants
according to whether or not they were of white European
descent, rather than more precise ethnic grouping, which
would have required hundreds of subjects per group.26
Nevertheless, whenwe restricted analyses to those born to
Black mothers (African or Afro-Caribbean origin) very
similar, albeit even stronger, associations were found.
Since many of the fullterm infants had been recruited to
clinical research studies as controls when investigating
the influence of Cystic Fibrosis on lung function, there
was a much lower proportion of non-white infants in this
group. However, despite the relatively small numbers,
highly significant reductions in FEV0.5 and FVC of the
same order of magnitude as seen in the preterm infants
were observed, with no difference in FEV0.5/FVC. This
suggests that the lower values seen in non-white preterm
infants did not reflect “worse” lung function or lung
disease, but simply ethnic differences in lung function as
observed in older subjects,26 possibly associated with
differences in body physique. Unfortunately we did not
record crown-rump length in relation to crown-heel
length in this study and hence are unable to comment on
its potential contribution to observed differences.
Although ethnic origin has been recognized as an
important determinant of pulmonary function in older
subjects,26–28 with similar evidence that such differences
may also occur during infancy and early childhood,29–32
the impact of ethnicity has rarely been taken into account
when examining the impact of prematurity on subsequent
pulmonary function. Current infant PFT reference
equations, including those used in the current study,16,19
are predominantly based on white infants. Results from
this study emphasize the need to expand these to other
ethnic groups or to recruit appropriate controls to studies
such as this.
The finding of relatively better pulmonary function in
boys than girls was unexpected, as most previous studies
have reported worse morbidity in male infants following
preterm birth.4,33,34 Given that investigation of sex
differences was not an a priori hypothesis and the
relatively small sample size once subsets were examined
according to ethnic group, gestational age sex and sex,
this finding needs to be interpreted with caution, as it
may simply reflect a chance finding due to sampling. In
addition, these findings may be biased by the fact that a
larger proportion of SGA infants were recruited to the
PTC than EP group (possibly reflecting the fact that such
children rarely survive if born EP) and that of these
children, twice as many were girls. We and others have
previously shown the adverse effects of SGA on
subsequent lung function,13,35 and it is possible that
while not appearing as a significant outcome on
multivariable analysis, this imbalance may have contrib-
uted to the apparent and unexpected sex difference that
we observed.
Given an imbalance ratio of 1.27, the sample size of 93
infants was equivalent to 45 per group,20 and hence
adequately powered to detect differences of at least 0.5
z-scores between EP and PTC groups with respect to the
FEFV outcomes. However, technical difficulties with
obtaining acceptable FRCpleth data in some infants reduced
the total sample size for this outcome to 76 infants, such
that a potentially important difference of 0.5 z-scores
between groups did not reach statistical significance
(Table 2). While the relatively lower FRCpleth in PTC
could be a chance observation, as discussed above, it
could also reflect the higher proportion of SGA infants in
this group.
Cancellations due to respiratory infections meant that
the EP group was, on average, 10 weeks older than the
PTC infants. However, use of age-adjusted reference
equations, derived from healthy term infants studied over
the first 2 years of life, means that this difference is
unlikely to have impacted on interpretation of results.
Deferment of testing for several weeks after any
respiratory illness also ensured that results better reflected
baseline lung and airway function rather than transient
inflammation due to any recent exacerbations.
With the exception of obvious differences in birth
characteristics, antenatal and postnatal care, the preterm
groups were well matched for factors such as ethnic
background, sex distribution and smoking exposure, all of
which can potentially confound interpretation of
PFTs.9,13,32 The incidence of maternal smoking reported
in this study was lower than previously reported32,35
which may reflect recent public health campaigns and
shifts in public opinion. While the very low reported
incidence of smoking during pregnancy could be due to
some recall bias or denial, cotinine analysis at time of test
confirmed reliability of reported postnatal smoking
habits. In contrast to previous reports including those
from our department,32,35 there was no significant impact
of maternal smoking on pulmonary function in this
population, which probably relates to the relatively small
numbers within each group that were exposed to passive
tobacco smoke pre- or post-natally.
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In this study, 79% of EP infants developed BPD, which
corresponded to a similar percentage to that reported in
both the original EPICure study36 and the more recent
EPICure 2 study.5 Despite the crudeness of defining BPD
simply on the basis of who remained in oxygen at
36 weeks postmenstrual age,22 we have previously shown
this to be a remarkably sensitive means of discriminating
those who go on to have long term respiratory
problems.3,37 Indeed, the pattern of pulmonary function
abnormalities observed in this population of infants at
around 1-year of age, bears a striking resemblance to that
seen at 11-years during the respiratory follow-up of the
1995 EPICure cohort3 (Fig. 4). It is of concern that a
similar decrement of PFT values is found in the current
cohort, despite improving perinatal care and survival.
Since insults to the developing lung may have life-long
effects, sub-optimal pulmonary function at a year of
age in those born preterm may persist through to
adulthood.2,3,7,37,38
Even in the absence of prolonged or aggressive
ventilator support, the lungs of infants with “new” BPD
are characterized by a simplified alveolar structure with
variable degrees of fibrosis.1,22 This combination of
disrupted alveolarization, contributing to poor airway
tethering, and airway thickening due to fibrosis contribute
to the long-term impairments of pulmonary function that
have been reported after preterm birth.1–3,37,39 Similar
reductions in pulmonary function have been reported in
preterm infants with BPD when compared either
with healthy term infants or preterm subjects without
BPD,40–42 with no evidence of catch up by 2-years of
age.41 Although recent studies have used similar
equipment to measure PF in infants born preterm, with
or without BPD,42,43 use of inappropriate reference
equations and/or standardizing outcomes by body weight,
both of which may bias interpretation of results16,19
precludes comparison with the current data.
Impaired airway function has been reported following
preterm delivery even in the absence of any neonatal lung
disease or ventilator support,39,44 as confirmed in this
study. Such changes may persist to childhood even in
relatively “late preterm” subjects,45 reflecting the critical
developmental changes that occur in the lungs during the
last trimester of pregnancy.
CONCLUSIONS
Results from this study indicate that it is essential to
account for ethnic differences in lung function when
interpreting the impact of early insults to the developing
lung. Despite recent improvements in maternal health
and neonatal care, preterm delivery continues to have a
negative impact on subsequent lung development, even in
relatively “mature” PTCs. Since impairment may persist
throughout childhood and into adult life, it is important
that carers and the children themselves are aware of this
association so that life-style is adjusted to preserve
available pulmonary function. The increased risks
following preterm delivery of developing more severe
acute childhood respiratory illnesses, as well as early
onset chronic lung disease in adulthood, also need to be
considered by physicians whenever such individuals
present with respiratory symptoms.
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